Search filters

List of works by Alexander Muik

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy

scientific article published on 28 September 2016

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

scientific article published in 2021

BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

scientific article published on 27 May 2021

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

scientific article

BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants

scientific article published on 8 April 2022

CD30-targeted oncolytic viruses as novel therapeutic approach against classical Hodgkin lymphoma

scientific article published on 12 January 2018

COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T-cell responses

scientific article published on 30 September 2020

Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect

scientific article

Comparison of three humanized mouse models for adoptive T cell transfer

scientific article published on 01 August 2012

Concurrent human antibody and TH1 type T-cell responses elicited by a COVID-19 RNA vaccine

preprint

Covalent coupling of high-affinity ligands to the surface of viral vector particles by protein trans-splicing mediates cell type-specific gene transfer

scientific article

Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective

scientific article published on 26 June 2017

Ligand Coupling to the AAV Capsid for Cell-Specific Gene Transfer

scientific article published on 01 January 2019

Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1.

scientific article published on 23 April 2013

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera

scientific article published on 19 January 2021

Off-target-free gene delivery by affinity-purified receptor-targeted viral vectors

scientific article published on 10 February 2015

Pseudotyping vesicular stomatitis virus with lymphocytic choriomeningitis virus glycoproteins enhances infectivity for glioma cells and minimizes neurotropism

scientific article published on 30 March 2011

Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses

correction of a scholarly article

Re-engineering vesicular stomatitis virus to abrogate neurotoxicity, circumvent humoral immunity, and enhance oncolytic potency

scientific article published on 8 May 2014

Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy

scientific article published on August 2012

VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.

scientific article published on 19 February 2014

Paulina is supported by:

About Paulina

Help